Akura Medical
United States
- Los Gatos, California
- 04/10/2023
- Series B
- $35,000,000
Focused on providing effective and easy-to-use clot removal to efficiently treat venous thromboembolisms (VTE)
- Industry Medical Device
- Website https://www.akuramed.com/
- LinkedIn https://www.linkedin.com/company/akura-med/about/
Related People
Murali SrivathsaFounder
United States -
San Francisco Bay Area
Mission-driven, versatile Medical Devices leader who can introduce bold solutions and strategic plans which drive rapid business and operational growth, translate cutting-edge concepts into game-changing commercial offerings, and seize emerging opportunities through a balanced mix of strategic partnerships, financial planning, and business due diligence. The answer to my "Why?" is to make a transformative change in the lives of patients and those who treat them.
✓ Consistently delivers high growth/profitability through vital blend of product innovation and commercialization, go-to-market strategies, transformational approaches to Education & Training, and operational plans. Proven business and leadership record honed across multiple functions from management to strategy, M&A, to R&D.
✓ Credited with leading matrix organizations in the development of next-gen product lines at Abbott and Guidant (Boston Scientific CRM), accounting for $900+Mn in annual revenues.
✓ Expert relationship management skills and emotional intelligence to build high-performance internal cross-functional teams, as well as long-lasting external strategic partnerships.
✓ Experience with building funding strategies and leading fundraises.
✓ Enjoys the challenges of new initiatives- excels at being able to add value with a singular combination of scientific and business acumen.
✓ Broad experience in both domestic and international markets.
Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)